Pet-yksikkö

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Airas L et al. Jäykkyysoireyhtymä.
2 Aittoniemi J et al. The effect of mannan-binding lectin variant alleles on coronary artery reactivity in healthy young men.
3 Antila S et al. Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators.
4 Bergström M et al. Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.
5 Bischof Delaloye A et al. Peter Ell: portrait of an editor.
6 Brück A et al. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson´s disease is related to cognitive impairment.
7 Eskola O et al. A novel electrophilic synthesis and evaluation of medium specific radioactivity (1R,2S)-4-(18F)fluorometaraminol, a tracer fo the assessment of cardiac sympathetic nerve integrity with PET.
8 Fagerholm V et al. Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice.
9 Fenyvesi A et al. Excitation functions of nuclear reactions incuded by 3He-particles on cobalt.
10 Forsback S et al. Uptake of 6-(18)Fluoro-L-Dopa and (18F)CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
11 Grönroos T et al. Comparison of the biodistribution of two hypoxia markers (18F)FETNIM and (18F)FMISO in an experimental mammary carcinoma .
12 Haaparanta M et al. In vivo sampling for pharmacokinetic studies in small experimental animals: a combination of microdialysis, planar chromatography and digital autoradiography.
13 Hagelberg N. Role of Dopamine Reseptors in Pain and Opioid Effects . Positron Emission Tomography Studies in Healthy Subjects and Patients with Chronic Orofacial Pain.
14 Hagelberg N et al. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
15 Hagelberg N et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review.
16 Hakala M et al. Volumes of the caudate nuclei in women with somatization disorder and healthy women.
17 Heikkilä J et al. Psychodynamic personality profile in first-episode severe mental disorders.
18 Heikkilä J et al. Family functioning, expressed emotion and family type in families with a first-episode severe metal disorder patient.
19 Hirvonen M et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.
20 Hällsten K. Glucose Uptake in Skeletal Muscle and Myocardium in Insulin Resistance. The Effect of Rosiglitazone Treatment.
21 Hällsten K et al. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.
22 Hällsten U et al. Oxygen reactions in high-pressure nitrogen gas studied with optical emission spectroscopy.
23 Hällsten U, Solin O. A method for calculating the energy distribution and yield of electrons ejected by protons in nitrogen gas targets.
24 Ilonen T et al. Neuropsychological subtyping of schizophrenia.
25 Iozzo P. Metabolic Regulation of Liver Glucose Uptake in Humans. Positron Emission Tomography Studies with Reference to Diabetes.
26 Iozzo P et al. Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.
27 Iozzo P et al. Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia.
28 Iozzo P et al. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance.
29 Janatuinen T et al. Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes.
30 Johansson B-L et al. C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients.
31 Juonala M et al. The 21-year follow-up of the cardiovascular risk in young Finns study: risk factor levels, secular trends and east-west difference.
32 Järvenpää T et al. Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs.
33 Järvisalo MJ et al. Determinants of arterial nitrate-mediated dilatation in children. Role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness.
34 Järvisalo MJ et al. Endothelial dysfunction and increased arterial intima-media thickness in children with Type 1 diabetes.
35 Kaasinen V et al. Expectation of caffeine induces dopaminergic responses in humans.
36 Kaasinen V et al. Insular dopamine D2 reseptors and novelty seeking personality in Parkinson´s disease.
37 Kaasinen V et al. Dopaminergic effects of caffeine in the human striatum and thalamus.
38 Kaisti K. The Effects of Sevoflurane, Propofol and Nitrous Oxide on Regional Cerebral Blood Flow, Oxygen Consumption and Blood Volume . Positron Emission Tomography and EEG Studies on Healthy Subjects.
39 Kaisti KK et al. Ventilator add-on for delivering PET tracer gases.
40 Kalliokoski KK et al. Blood transit time heterogeneity is associated to oxygen extraction in exercising human skeletal muscle.
41 Kalliokoski KK et al. Myocardial perfusion after marathon running.
42 Karlsson H. The many consequences of trauma.
43 Karlsson H, Katila H. Interpersonal psychotherapy: a well studied research treatment gaining popularity among clinicians.
44 Knuuti J. Positron emission tomography - Molecular imaging of biological processes.
45 Knuuti J. Clinical cardiac PET in the future.
46 Knuuti J et al. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronisation therapy.
47 Koort J et al. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing.
48 Koponen H, Hietala J. Psykoosilääkkeen valinnan kliinis-farmakologiset perusteet.
49 Kotilainen P et al. Positron emission tomography as an aid in the diagnosis and follow-up of Riedel's thyroiditis.
50 Kouri M et al. Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.
51 Kunnas TA et al. Estrogen receptor genotype modulates myocardial perfusion in young men.
52 Kämäräinen E-L et al. Preparation of fluorine-18-labelled fluoromisonidazole using two different synthesis methods.
53 Laatu.S et al. Visual object recognition deficits in early Parkinson´s disease.
54 Laine H et al. Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes.
55 Laine K et al. Effect of the novel anxiolytic drug deramciclane on cytochrome P450 2D6 activity as measured by desipramine pharmacokinetics.
56 Laitio TT et al. The breakdown of fractal heart rate dynamics predicts prolonged postoperative myocardial ischemia.
57 Lankinen PS et al. PET-kuvauksen ja tietokonetomografian käyttö osteomyeliitin aktiviteetin arvioinnissa.
58 Lehtiö K et al. Imaging perfusion and hypoxia with PETto predict radiotherapy response in head-and-neck cancer.
59 Luoma P et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
60 Långsjö JW et al. Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans.
61 Mikkilä V et al. Longitudinal changes in diet from childhood into adulthood with respect to risk of cardiovascular diseases: The Cardiovascular risk in young Finns study.
62 Minn H et al. Imaging of adrenal incidentalomas with PET using 11C-metomidate and 18F-FDG.
63 Muhonen A et al. Osteoblastic activity and neoangiogenesis in distracted bone of irradiated rabbit mandible with or without hyperbaric oxygen treatment.
64 Mäkelä R et al. Myeloperoxidase gene variation and coronary flow reserve in young healthy men.
65 Mäkinen TJ et al. Antibioottia vapauttava bioliukeneva ruuvi estää vierasesineinfektion kehittymisen.
66 Nieminen-von Wentdt TS et al. Increased presynaptic dopamine function in Asperger syndrome .
67 Pekkola K et al. Permanent in vitro growth is associated with poor prognosis in head and neck cancer.
68 Penttilä J et al. Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects.
69 Penttilä J et al. Effects of atipamezole - a selective alfa2-adrenoceptor antagonist - on cardiac parasympathetic regulation in human subjects.
70 Penttilä J et al. Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with (11C)raclopride.
71 Penttinen M et al. Fabryn tauti ja suositus sen diagnostiikasta, seurannasta ja hoitolinjoista Suomessa.
72 Pertovaara A et al. Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain.
73 Raitakari M et al. Weigth reduction with very-low-caloric diet and endothelial function in overweight adults: Role of plasma glucose.
74 Rinne JO et al. Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with (11C)-CFT.
75 Rinne JO et al. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
76 Roivainen A et al. Biodistribution and blood metabolism of 1-11C -methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET.
77 Roivainen A et al. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
78 Saarela MS et al. Interaction between matrix metalloproteinase 3 and epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
79 Saariluoma P et al. Visuospatial representations used by chess experts: A preliminary study.
80 Salmi E et al. Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans.
81 Salokangas RKR et al. Vulnerability to and current risk of psychosis.
82 Sihvo EIT et al. Adenocarcinoma of the esophagus and the esophagogastric junction: Positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
83 Solin O et al. Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: (18F)SPA-RQ).
84 Stolen KQ et al. Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy.
85 Stolen KQ et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy.
86 Sundell J et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
87 Sundell J, Luotolahti M. Association between insulin resistance and reduced coronary vasoreactivity in healthy subjects.
88 Sundell J et al. Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes.
89 Sundell J et al. High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.
90 Sutinen E . Methodological and Clinical Studies on Positron Emission Tomography (PET) in Oncology. With Special Reference to Radiopharmaceuticals Marking Amino Acid and Phospholipid Metabolism.
91 Sutinen E et al. Kinetics of [11C]choline uptake in prostate cancer: a PET study.
92 Tiihonen J et al. Brain serotonin 1 A receptor binding in bulimia nervosa.
93 Tuominen S et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients.
94 Underwood SR et al. Imaging techniques for the assessment of myocardial hibernation. Report of a study group of the European Society of Cardiology.
95 Verkkoniemi A et al. Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis.

Julkaisutietokanta 26.10.2005 Publications Data Base 26.10.2005